Resonance Specialties Limited (BOM:524218)
138.45
-1.40 (-1.00%)
At close: Jun 19, 2026
Resonance Specialties Revenue
In the fiscal year ending March 31, 2026, Resonance Specialties had annual revenue of 902.48M INR with 15.99% growth. Resonance Specialties had revenue of 244.77M in the quarter ending March 31, 2026, with 1.14% growth.
Revenue
902.48M
Revenue Growth
+15.99%
P/S Ratio
1.77
Revenue / Employee
13.67M
Employees
66
Market Cap
1.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 902.48M | 124.41M | 15.99% |
| Mar 31, 2025 | 778.07M | 225.06M | 40.70% |
| Mar 31, 2024 | 553.01M | -35.14M | -5.97% |
| Mar 31, 2023 | 588.15M | -169.43M | -22.36% |
| Mar 31, 2022 | 757.57M | 48.62M | 6.86% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.72B |
| Influx Healthtech | 1.47B |
| Kimia Biosciences | 1.15B |
| Panchsheel Organics | 1.07B |
| Smruthi Organics | 1.02B |
| Tyche Industries | 628.56M |
| Vasundhara Rasayans | 357.23M |
| Accretion Nutraveda | 337.16M |